Two Sigma Advisers’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-267,500
| Closed | -$1.56M | – | 2604 |
|
|
2025
Q1 | $1.56M | Buy |
267,500
+13,800
| +5% | +$72.7K | ﹤0.01% | 1258 |
|
|
2024
Q4 | $944K | Sell |
253,700
-31,200
| -11% | -$144K | ﹤0.01% | 1485 |
|
|
2024
Q3 | $1.59M | Sell |
284,900
-136,700
| -32% | -$956K | ﹤0.01% | 1190 |
|
|
2024
Q2 | $3.55M | Sell |
421,600
-80,600
| -16% | -$859K | 0.01% | 913 |
|
|
2024
Q1 | $7.25M | Sell |
502,200
-17,500
| -3% | -$289K | 0.02% | 632 |
|
|
2023
Q4 | $11.2M | Sell |
519,700
-5,400
| -1% | -$96.4K | 0.03% | 484 |
|
|
2023
Q3 | $10.1M | Sell |
525,100
-21,900
| -4% | -$467K | 0.03% | 462 |
|
|
2023
Q2 | $13.9M | Buy |
547,000
+11,400
| +2% | +$329K | 0.04% | 393 |
|
|
2023
Q1 | $19.4M | Buy |
535,600
+172,400
| +47% | +$6.05M | 0.05% | 341 |
|
|
2022
Q4 | $14.4M | Sell |
363,200
-6,600
| -2% | -$274K | 0.04% | 417 |
|
|
2022
Q3 | $17.2M | Buy |
369,800
+51,000
| +16% | +$2.37M | 0.05% | 357 |
|
|
2022
Q2 | $14M | Buy |
318,800
+78,900
| +33% | +$4.34M | 0.04% | 413 |
|
|
2022
Q1 | $17.4M | Buy |
239,900
+104,100
| +77% | +$7.51M | 0.05% | 355 |
|
|
2021
Q4 | $11M | Buy |
+135,800
| New | +$13.6M | 0.03% | 479 |
|
|
2021
Q2 | – | Sell |
-97,700
| Closed | -$13.6M | – | 2739 |
|
|
2021
Q1 | $13.6M | Sell |
97,700
-38,200
| -28% | -$6.23M | 0.04% | 462 |
|
|
2020
Q4 | $23.5M | Sell |
135,900
-34,800
| -20% | -$5.64M | 0.06% | 309 |
|
|
2020
Q3 | $23.8M | Sell |
170,700
-61,400
| -26% | -$8.2M | 0.07% | 277 |
|
|
2020
Q2 | $27.7M | Sell |
232,100
-23,400
| -9% | -$2.78M | 0.08% | 261 |
|
|
2020
Q1 | $25.5M | Buy |
255,500
+102,600
| +67% | +$12.3M | 0.1% | 243 |
|
|
2019
Q4 | $18M | Buy |
+152,900
| New | +$15.1M | 0.04% | 415 |
|
|
2016
Q4 | – | Sell |
-6,700
| Closed | -$699K | – | 2476 |
|
|
2016
Q3 | $699K | Buy |
+6,700
| New | +$605K | ﹤0.01% | 1516 |
|
|
2015
Q3 | – | Sell |
-9,901
| Closed | -$532K | – | 2015 |
|
|
2015
Q2 | $532K | Buy |
+9,901
| New | +$504K | ﹤0.01% | 1402 |
|
Other funds holding NVRO
Two Sigma Advisers's NVRO Position: Q2 2025 in Review
Two Sigma Advisers sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 267,500 shares — an estimated $1.56M sold.
Two Sigma Advisers first reported a position in NVRO in Q2 2015 and held it in 22 quarters. The position peaked at $27.7M in Q2 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Two Sigma Advisers reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Two Sigma Advisers sold 267,500 NEVRO CORP. shares in Q2 2025, an estimated $1.56M.
- Two Sigma Advisers first reported a position in NEVRO CORP. in Q2 2015 and held it in 22 quarters.
- Two Sigma Advisers's NEVRO CORP. position peaked at $27.7M in Q2 2020.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Two Sigma Advisers's 13F filing for Q2 2025, filed 14 Aug 2025.